Base
Proposed Rule2024-119872024-05-31

Hazard Analysis and Risk-Based Preventive Controls for Human Food; Draft Guidance for Industry; Appendix 1; Extension of Comment Period

Health and Human Services Department, Food and Drug Administration

Abstract

The Food and Drug Administration (FDA, we, or the Agency) is extending the comment period for a revised draft Introduction, and a revised draft Appendix 1, within a multichapter guidance for industry entitled "Hazard Analysis and Risk-Based Preventive Controls for Human Food" which were announced in the Federal Register of February 2, 2024. We are taking this action in response to a request for an extension to allow interested persons additional time to submit comments before FDA begins work on the final guidance.

Action & Dates

Action
Notification of availability; extension of comment period.
Dates
FDA is extending the comment period on our draft guidance published February 2, 2024 (89 FR 7315). Submit either electronic or written comments by August 2, 2024, to ensure that the Agency considers your comment on this draft guidance before it begins work on the final guidance.

CFR References

Public Comment

Comments Close
2024-08-02

Document Excerpt

Document Headings Document headings vary by document type but may contain the following: the agency or agencies that issued and signed a document the number of the CFR title and the number of each part the document amends, proposes to amend, or is directly related to the agency docket number / agency internal file number the RIN which identifies each regulatory action listed in the Unified Agenda of Federal Regulatory and Deregulatory Actions See the Document Drafting Handbook for more details. Department of Health and Human Services Food and Drug Administration 21 CFR Part 117 [Docket No. FDA-2016-D-2343] ( printed page 47108) AGENCY: Food and Drug Administration, HHS. ACTION: Notification of availability; extension of comment period. SUMMARY: The Food and Drug Administration (FDA, we, or the Agency) is extending the comment period for a revised draft Introduction, and a revised draft Appendix 1, within a multichapter guidance for industry entitled “Hazard Analysis and Risk-Based Preventive Controls for Human Food” which were announced in the Federal Register of February 2, 2024. We are taking this action in response to a request for an extension to allow interested persons additional time to submit comments before FDA begins work on the final guidance. DATES: FDA is extending the comment period on our draft guidance published February 2, 2024 ( 89 FR 7315 ). Submit either electronic or written comments by August 2, 2024, to ensure that the Agency considers your comment on this draft guidance before it begins work on the final guidance. ADDRESSES: You may submit comments on any guidance at any time as follows. Electronic Submissions Submit electronic comments in the following way: Federal eRulemaking Portal: https://www.regulations.gov . Follow the instructions for submitting comments. Comments submitted electronically, including attachments, to https://www.regulations.gov will be posted to the docket unchanged. Because your comment will be made public,…

Read full document on FederalRegister.gov →

Related Documents

Other Federal Register documents from the same docket.

Full Document

Citation: 89 FR 47108